SCHEMBL4376036

SCHEMBL4376036

CC12C[CH]C(CC1)C2(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21522974 0.60
SCHEMBL10486984 0.60 KDM4E (0.31)
SCHEMBL22370069 0.59
SCHEMBL494491 0.58
SCHEMBL1031219 0.58 CTDSP1 (0.50)
SCHEMBL8427 0.58 CTDSP1 (0.50)
SCHEMBL17627829 0.58 CTDSP1 (0.50)
SCHEMBL6889168 0.55
SCHEMBL9012417 0.55
SCHEMBL1069898 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303539-A1 IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-09-28 US claimed
WO-2023151635-A1 COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF 标新生物医药科技(上海)有限公司 2023-08-17 WO claimed
US-20230203022-A1 HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-06-29 US claimed
EP-4198030-A1 IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF Shanghaitech University (CN) 2023-06-21 EP claimed
US-20230096517-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-03-30 US claimed
EP-4144728-A1 HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF Shanghaitech University (CN) 2023-03-08 EP claimed
EP-4112614-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF Shanghaitech University (CN) 2023-01-04 EP claimed
EP-2929397-B1 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) 2020-03-18 EP claimed
EP-2929397-A2 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2015-10-14 EP claimed
US-8841062-B2 Positive working photosensitive material AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) 2014-09-23 US claimed
WO-2014086846-A2 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2014-06-12 WO claimed
US-7563910-B2 Heterocyclic cannabinoid receptor antagonists HOFFMANN-LA ROCHE INC. (US) 2009-07-21 US claimed
EP-1749002-B1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY HOFFMANN LA ROCHE (CH) 2009-05-27 EP claimed
EP-1749002-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F.HOFFMANN-LA ROCHE AG (CH) 2007-02-07 EP claimed
WO-2005108393-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F. HOFFMANN-LA ROCHE AG (CH) 2005-11-17 WO claimed
US-20050250769-A1 Heterocyclic cannabinoid receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 2005-11-10 US claimed
EP-0423127-A1 NOVEL PHOTOACTIVE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND INTERMEDIATES THEREFOR TRAQSON LIMITED (GB) 1991-04-24 EP claimed
EP-0334477-A2 Novel photoactive compounds, processes for their production and intermediates therefor MTM RESEARCH CHEMICALS LIMITED (GB) 1989-09-27 EP claimed
WO-1989007597-A2 NOVEL PHOTOACTIVE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND INTERMEDIATES THEREFOR TRAQSON LIMITED (GB) 1989-08-24 WO claimed
WO-2024140637-A1 OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-07-04 WO disclosed
WO-2024051766-A1 MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-03-14 WO disclosed
US-20230303539-A1 IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-09-28 US disclosed
WO-2023151635-A1 COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF 标新生物医药科技(上海)有限公司 2023-08-17 WO disclosed
US-20230203022-A1 HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-06-29 US disclosed
EP-4198030-A1 IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF Shanghaitech University (CN) 2023-06-21 EP disclosed
US-20230096517-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2023-03-30 US disclosed
CN-108885396-B Positive working photosensitive material 默克专利有限公司 2023-03-24 CN disclosed
EP-4144728-A1 HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF Shanghaitech University (CN) 2023-03-08 EP disclosed
EP-4112614-A1 GLUTARIMIDE SKELETON-BASED COMPOUNDS AND APPLICATION THEREOF Shanghaitech University (CN) 2023-01-04 EP disclosed
US-10976662-B2 Positive working photosensitive material MERCK PATENT GMBH (DE) 2021-04-13 US disclosed
CN-107531978-B Methacrylic resin composition 株式会社可乐丽 2020-11-03 CN disclosed
EP-3446180-B1 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) 2020-04-01 EP disclosed
EP-2929397-B1 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) 2020-03-18 EP disclosed
WO-2020027304-A1 NOVEL CAROTENOID-RELATED DERIVATIVES, AND SALTS, ESTERS, OR AMIDES THEREOF アスタファーマシューティカルズ株式会社 2020-02-06 WO disclosed
US-20190168493-A1 MOLDED BODY COMPRISING ACRYLIC RESIN COMPOSITION KURARAY CO., LTD. (JP) 2019-06-06 US disclosed
EP-3476595-A1 MOLDED BODY COMPRISING ACRYLIC RESIN COMPOSITION Kuraray Co., Ltd. (JP) 2019-05-01 EP disclosed
EP-3284784-A1 METHACRYLIC RESIN COMPOSITION Kuraray Co., Ltd. (JP) 2018-02-21 EP disclosed
EP-2929397-A2 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2015-10-14 EP disclosed
US-8841062-B2 Positive working photosensitive material AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) 2014-09-23 US disclosed
WO-2014086846-A2 POSITIVE WORKING PHOTOSENSITIVE MATERIAL AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2014-06-12 WO disclosed
US-7563910-B2 Heterocyclic cannabinoid receptor antagonists HOFFMANN-LA ROCHE INC. (US) 2009-07-21 US disclosed
EP-1749002-B1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY HOFFMANN LA ROCHE (CH) 2009-05-27 EP disclosed
US-20070059546-A1 One solution-type thermosetting compositions for color filter protective films and color filters using the same CHEIL INDUSTRIES, INC. 2007-03-15 US disclosed
EP-1749002-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F.HOFFMANN-LA ROCHE AG (CH) 2007-02-07 EP disclosed
WO-2005108393-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F. HOFFMANN-LA ROCHE AG (CH) 2005-11-17 WO disclosed
US-20050250769-A1 Heterocyclic cannabinoid receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 2005-11-10 US disclosed
US-20050250769-A1 Heterocyclic cannabinoid receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 2005-11-10 US disclosed